Parexel launches an enhanced integrated outsourcing delivery model for FSP

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...

June 24, 2019 | Monday | News
EC approves Pfizer's TALZENNA

Pfizer has announced that the European Commission approved TALZENNA  (talazoparib), an oral poly (ADP-rib...

June 24, 2019 | Monday | News
Canon Medical Showcases New Ultrasound Product Line at ASE 2019

Canon Medical Systems USA, Inc. is showcasing its innovative new line of ultrasound systems, the Aplio a-series, at this...

June 24, 2019 | Monday | News
FDA approves Vertex's SYMDEKO

Vertex Pharmaceuticals Incorporated has announced that the U.S. Food and Drug Administration (FDA) approved SYMDEKO (tez...

June 24, 2019 | Monday | News
Agilent invests$185M in new facility to develop Oligos

Agilent Technologies Inc. has announced the opening of a production facility in Colorado that more than doubles its capa...

June 24, 2019 | Monday | News
Regeneron, Sanofi announce positive results for IL-33 antibody for asthma

Regeneron Pharmaceuticals and Sanofi have announced that a Phase 2 proof-of-concept trial evaluating the investigational...

June 21, 2019 | Friday | News
PDS Biotechnology Corp gets U.S. and European patents for Versamune

PDS Biotechnology Corporation, a clinical-stage immuno-oncology company pioneering the development of novel multifu...

June 21, 2019 | Friday | News
Optum completes acquisition of DaVita Medical Group from DaVita

Optum, a leading health services company, completed its acquisition of DaVita Medical Group, one of the nation’s l...

June 21, 2019 | Friday | News
Servier lays foundation stone for new research institute

Servier, an independent international pharmaceutical company, has laid the foundation stone of its future Research Insti...

June 21, 2019 | Friday | News
Edesa Biotech receives approval to proceed with its clinical investigation

Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration h...

June 20, 2019 | Thursday | News
Verastem Oncology announces leadership changes

Verastem,  a biopharmaceutical company focused on developing and commercializing medicines seeking to improve ...

June 20, 2019 | Thursday | News
Novo Nordisk’ Victoza gets FDA nod to treat type 2 diabetes

Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Vict...

June 20, 2019 | Thursday | News
Gilead collaborates with Nurix to develop new cancer therapies

Gilead Sciences and Nurix Therapeutics, Inc., have announced a global strategic collaboration to discover, dev...

June 21, 2019 | Friday | News
Genocea announces pricing of $36,750,000 public offering of common stock

Genocea Biosciences, a biopharmaceutical company developing personalized cancer immunotherapies has announced the p...

June 20, 2019 | Thursday | News
Invivoscribe LeukoStrat CDx FLT3 Mutation Test approved for treating R/R AML with FLT3 –ITD

Invivoscribe, announced that on 5 June 2019, the Ministry of Health, Labour and Welfare (MHLW) approved LeukoStrat®&...

June 20, 2019 | Thursday | News
Cognizant to acquire Zenith Technologies

Cognizant has agreed to acquire Zenith Technologies, a privately-held life sciences manufacturing technology S...

June 19, 2019 | Wednesday | News
Ferring Pharma collaborates with WOOM

Ferring Pharmaceuticals and WOOM have announced a collaboration, which aims to improve and shorten the fertility journey...

June 19, 2019 | Wednesday | News
Stoke Therapeutics announces pricing of IPO

Stoke Therapeutics, Inc., a biotechnology company that is pioneering a new way to treat the underlying cause of genetic ...

June 19, 2019 | Wednesday | News